Skip to content

Insider · CIK 0001816206

Van Hauwermeiren Timothy

Reports to the SEC for 4 companies · NEW YORK, NY

Transactions

17

Companies

4

Filings

14

CIK

0001816206

Forms 4 and 5

Insider transactions

17 trades
DateCompanyValue
2026-06-25LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award—
2026-06-03DNLIDenali Therapeutics Inc.A Award—
2026-06-03DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award—
2025-11-04DNLIDenali Therapeutics Inc.A Award—
2025-11-04DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award—
2025-06-26LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award—
2025-05-13iTeos Therapeutics, Inc.M Exercise/Conversion+$96.1K
2025-05-13iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion—
2024-07-05LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award—
2024-06-11iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2024-02-26RayzeBio, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2023-11-01RayzeBio, Inc.Stock Option (right to buy)A Award—
2023-06-13iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2022-06-09iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2021-06-17iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2020-07-23iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2020-07-23iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award—

Recent filings

14

Companies

4

Address

C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, FLOOR 6

NEW YORK, NY, 10010